SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-031637
Filing Date
2017-05-11
Accepted
2017-05-10 17:37:11
Documents
3
Period of Report
2017-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-12875_18k.htm 8-K 24039
2 EX-99.1 a17-12875_1ex99d1.htm EX-99.1 92387
3 GRAPHIC g128751mm01i001.jpg GRAPHIC 3086
  Complete submission text file 0001104659-17-031637.txt   121948
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35619 | Film No.: 17831710
SIC: 2834 Pharmaceutical Preparations